Higher tax outgo pulls Aurobindo's Q4 net profit down 12%

Impacted by higher tax outgo, pharma major Aurobindo Pharma’s posted a 12% drop in consolidated net profit for the fourth quarter ended March 31, 2023, at Rs 506 crore as compared to Rs 576 crore in the corresponding quarter of financial year 2021-22.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/7NhKYBq

Comments

Popular posts from this blog

ICICI sought to acquire HDFC, reveals chairman Deepak Parekh

Sony says no extension of merger deadline yet